Kalos Therapeutics, Inc. Kalos Therapeutics, Inc. is a biomedical company targeting diseases caused by an abnormally high growth rate of cells (hyper-proliferation). Our initial therapeutic focus is on cancer with testing being done on therapeutic approaches to treating age-related macular degeneration (AMD),our strategy is to leverage the natural antiproliferative activity of the Atrial Natriuretic Peptide (ANP) family of peptides. Kalos has identified the motif in this family of peptides that is responsible for controlling cell growth (the anti-cell proliferation motif, or ACM), and is developing a new class of anti-proliferative drugs based on this motif.